Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2017-07-17
Original market date: See footnote 1
1983-12-31
Product name:
PEDIAZOLE
DIN:
00583405
Product Monograph/Veterinary Labelling:
Date:
2009-06-03
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
AMDIPHARM LIMITED
TEMPLE CHAMBERS
3 Burlington Road
Dublin
Leinster
Ireland
DUBLIN 4
Class:
Human
Dosage form(s):
Powder For Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.12.04 , 08:12.20
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01RA02 SULFONAMIDES, COMBINATIONS WITH OTHER ANTIBACTERIALS (EXCL.TRIMETHOPRIM)
Active ingredient group (AIG) number:See footnote5
0252046001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ERYTHROMYCIN (ERYTHROMYCIN ETHYLSUCCINATE) | 200 MG / 5 ML |
| SULFISOXAZOLE (SULFISOXAZOLE ACETYL) | 600 MG / 5 ML |